search

Tarsus Pharmaceuticals Inc (TARS)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Tarsus Pharmaceuticals Names Neera Clase Chief Commercial Officer
Oct 29, 2026

Tarsus Pharmaceuticals Names Neera Clase Chief Commercial Officer

Tarsus Pharmaceuticals Inc. has appointed Neera Clase as its new chief commercial officer, effective November 1, 2026. Clase, who previously served as interim CCO and senior vice president of market access, will lead commercial strategy, focusing on expanding Xdemvy's reach and advancing the company's pipeline, which includes retina programs and treatments for ocular rosacea and Lyme disease. CEO Bobby Azamian praised her instrumental role in Xdemvy's market success, anticipating her leadership will drive future growth.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Somewhat-Bullish